Call 785-505-3300 to schedule.

Stay Informed

Join our email list to receive information about events and educational resources.

3D mammograms for advanced early detection, close to home

Call or Walk in for a 3D Screening Mammogram Today

Why are 3D breast cancer screenings so important? Because one in every eight women experiences breast cancer at some point in life. Early detection through annual 3D mammograms helps identify breast cancer sooner, when it is smaller and treatments are typically more successful.

With the latest 3D technology available at our Breast Centers, you have convenient access to the advanced breast cancer detection tools you need, close to home or work.

When breast cancer is detected early enough, the five-year survival rate is nearly 100%.

American Cancer Society10

The Benefits of 3D Mammograms

3D mammography enables doctors to examine breast tissue layer by layer, revealing the finest of details with greater clarity. Compared to conventional 2D mammograms, research shows 3D mammography:

  • Detects breast cancers earlier and with greater accuracy1-7
  • Finds 20-65% more invasive breast cancers8
  • Reduces unnecessary callbacks by up to 40%2,5

We follow the American College of Radiology guidelines for mammography: Starting at age 40, we encourage all women to have a screening mammogram every year. That’s why we offer state-of-the-art 3D technology, and that’s why we make your mammogram visit quick, comfortable and convenient. Call or walk in for your 3D screening mammogram today, and visit us again every year.

Comprehensive Breast Cancer Care

In addition to state-of-the-art breast cancer screening, our physicians and staff are dedicated to excellence in breast cancer care coordination. Our onsite breast surgeon provides same-day diagnostic results whenever possible, and when breast cancer is detected, our physicians combine advanced breast-imaging technology, 3D mammography, ultrasound and biopsy to create customized treatment plans for highly personalized care.

Learn more about multidisciplinary cancer care excellence at the LMH Health Oncology Center.

Our locations

* National guidelines recommend regular mammograms as a key to good breast health care. At LMH, we follow the American College of Radiology guidelines for mammography. Please consult with your personal physician with questions about your mammogram.


1 FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005.
2 Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
3 Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.
4 Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
5 Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
6 McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
7 Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.
8 Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.
9 American Cancer Society. Breast Cancer Survival Rates. Based on Howlader N, et al. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD,, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.